Verinurad and Allopurinol Combination Lowers SUA Levels but Fails to Improve HFpEF Outcomes, AMETHYST Trial Finds Medha Baranwal4 Sept 2024 9:00 AM ISTUSA: In a recent clinical trial, the combination of verinurad and allopurinol demonstrated a notable reduction in serum uric acid (SUA) levels in...
Among gout patients, Flare Risk similar during initiation and titration of Allopurinol and Febuxostat: Study Dr Riya Dave12 July 2024 7:00 AM ISTResearchers in a recent study have found that the risk of gout flares is similar during the initiation and titration of allopurinol and febuxostat...
Lupin bags USFDA nod for hyperuricemia treatment drug Febuxostat Ruchika Sharma19 Jan 2024 1:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
Phase 2 Outcomes of novel agent Shows Promise Against Tophaceous Gout Jacinthlyn Sylvia11 Dec 2023 5:00 PM ISTThe novel URAT1 inhibitor, AR882 exhibited robust and sustained serum urate (sUA) reduction in t Phase 2b trial in treating gout and tophaceous gout....
DRESS syndrome tied to high risk of complications in elderly, mainly kidney involvement and sepsis: Study Medha Baranwal21 Oct 2023 10:30 AM ISTTunisia: A recent study has revealed that drug reaction with eosinophilia and systemic symptoms (DRESS) in the elderly is associated with a high...
Febuxostat and Allopurinol Have Similar Hepatic Safety Profiles in Gout Patients Jacinthlyn Sylvia7 Oct 2023 9:45 AM ISTGout, a painful form of arthritis caused by excess uric acid in the blood, often requires long-term management, making the assessment of medication...
Allopurinol significantly lowers risk for neurodegenerative diseases Aditi27 May 2023 10:00 AM ISTUSA: Researchers have found in a recent study an association between allopurinol and a lower risk of neurodegenerative diseases.The findings of...
Allopurinol lowers risk of macular edema among diabetes patients Medha Baranwal16 Feb 2023 8:00 PM ISTUSA: A recent study published in Ocular Immunology and Inflammation has shown that allopurinol could reduce the risk of diabetic macular edema (DME)....
Zydus Lifesciences bags USFDA nod for Febuxostat Tablets to treat high uric acid Ruchika Sharma11 Jan 2023 11:47 AM ISTAhmedabad: Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug...
Older patients with CKD who started allopurinol at higher risk of severe cutaneous reaction Dr. Shravani Dali11 Dec 2022 8:00 PM ISTOlder patients with CKD who started allopurinol at >100 mg/d versus <100 mg/d were twice as likely to visit a hospital with a severe cutaneous...
Use of Allopurinol Associated with Lower Risk of First Coronary Event among gout patients Dr. Kamal Kant Kohli16 Nov 2022 9:30 AM ISTSweden: Gout patients who take allopurinol have a lower risk of developing their first acute coronary syndrome (ACS), according to research published...
Allopurinol tied to less mortality compared to febuxostat among patients with CVD Aditi4 Nov 2022 8:00 PM ISTChina: A study published in the Frontiers in Pharmacology mentioning a comparison between Allopurinol and Febuxostat has concluded that allopurinol...
